{"lastClose": 17.360000610351562, "len": 662, "date": "2023-04-05", "alpha_1": 0.917329389256841, "beta_1": 2.0333907972201453, "drawup_1": 2.911971835715504, "sharpe_1": 0.09902799133396932, "natr_1": 11.974030054172175, "sup_1": -0.22023818418072633, "res_1": 0.05376335107372605, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 37.096034996605056, "adx_1": 35.31607106964213, "drawdown_1": -0.6439615399452838, "stratHoldSharpe_1": 0.0899886356245422, "stratHoldAlpha_1": 251.07868263367286, "stratHoldDrawdown_1": -0.5797107362814466, "alpha_3mo": -0.6908966317782832, "beta_3mo": 1.2820291408991116, "drawup_3mo": 0.22638953542139606, "natr_3mo": 11.974030054172175, "sup_3mo": -0.04761911040208138, "res_3mo": 0.07382867263482186, "bullPattern_3mo": [], "bearPattern_3mo": ["SHORTLINE"], "rsi_3mo": 31.09503525640647, "adx_3mo": 48.735114946250086, "drawdown_3mo": -0.36035368457035033, "stratHoldSharpe_3mo": -2.2617463169872436, "stratHoldAlpha_3mo": 249.85000853570733, "stratHoldDrawdown_3mo": -0.3276503539624931, "IPO Year": 2020.0, "Industry": "Biotechnology: Pharmaceutical Preparations", "Country": "United States", "Market Cap": 756410962, "Name": "Inhibrx Inc.", "Sector": "Health Care", "alpha%_1": 0.998718459294981, "beta%_1": 0.9853193649202939, "drawup%_1": 0.9999999999833028, "sharpe%_1": 0.26085676561149473, "natr%_1": 0.9992357093333918, "drawdown%_1": 0.07970210989503351, "stratHoldSharpe%_1": 0.5730892576025554, "stratHoldAlpha%_1": 0.637378401928727, "stratHoldDrawdown%_1": 0.08397876325357523, "alpha%_3mo": 0.17294693225460545, "beta%_3mo": 0.6469518132132901, "drawup%_3mo": 0.6656226499208369, "natr%_3mo": 0.9990094601521571, "drawdown%_3mo": 0.08193601248730137, "stratHoldSharpe%_3mo": 0.09851592077984245, "stratHoldAlpha%_3mo": 0.029236892234094366, "stratHoldDrawdown%_3mo": 0.08278245685589763}